Eligible Medicare beneficiaries will continue to have access to covered GLP-1 medications nationwide with a fixed $50 copay through the extended Bridge Model
Treatment duration varies by individual
Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus
It does not always mean the treatment has failed
However, the company obtained supplementary protection certificates (SPCs) in most EU member states, extending protection by up to 5 years
Licensed prescribers MDs, DOs, NPs, PAs in most states already have the authority to prescribe semaglutide, tirzepatide, oral Wegovy, and Foundayo for appropriate indications